Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1104 A safe and highly potent PD-1-IL-2 fusion (AWT020) that decouples the efficacy and toxicity of IL-2 therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.